Ctt Pharmaceutical Holdings, Inc. bought $1,401 of CTTH
CEO at CTT PHARMACEUTICAL HOLDINGS, INC.. 23,346 shares at an average of $0.06, traded Nov 25, 2024, filed Nov 26, 2024.
Score components
- +25RoleCEO
- 0Trade size$1k at market
- -5Relative to holdingsUnder 1% of holdings (0.4%)
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001035422-24-000026, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 25, 2024 | POpen-market purchase CTTH | +23,346 | $0.06 | $1,401 | 5,818,846 | Nov 26, 2024 |
Related signals
Other insiders at CTT PHARMACEUTICAL HOLDINGS, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 33Weak | CTTHbuy CTT PHARMACEUTICAL HOLDINGS, INC. | Ctt Pharmaceutical Holdings, Inc. CEO | $204 3,700 shares | +0% | |
| 33Weak | CTTHbuy CTT PHARMACEUTICAL HOLDINGS, INC. | Ctt Pharmaceutical Holdings, Inc. CEO | $455 10,100 shares | +0% | |
| 33Weak | CTTHbuy CTT PHARMACEUTICAL HOLDINGS, INC. | Ctt Pharmaceutical Holdings, Inc. CEO | $187 3,400 shares | +0% | |
| 33Weak | CTTHbuy CTT PHARMACEUTICAL HOLDINGS, INC. | Ctt Pharmaceutical Holdings, Inc. CEO | $455 10,100 shares | +1% | |
| 33Weak | CTTHbuy CTT PHARMACEUTICAL HOLDINGS, INC. | Ctt Pharmaceutical Holdings, Inc. CEO | $523 10,900 shares | +0% | |
| 33Weak | CTTHbuy CTT PHARMACEUTICAL HOLDINGS, INC. | Ctt Pharmaceutical Holdings, Inc. CEO | $175 3,500 shares | +0% | |
| 25Weak | CTTHbuy CTT PHARMACEUTICAL HOLDINGS, INC. | Ctt Pharmaceutical Holdings, Inc. CEO | $479 9,800 shares | +0% | |
| 20Weak | CTTHbuy CTT PHARMACEUTICAL HOLDINGS, INC. | Ctt Pharmaceutical Holdings, Inc. CEO | $147 3,000 shares | +0% | |
| 33Weak | CTTHbuy CTT PHARMACEUTICAL HOLDINGS, INC. | Ctt Pharmaceutical Holdings, Inc. CEO | $990 39,600 shares | +1% | |
| 33Weak | CTTHbuy CTT PHARMACEUTICAL HOLDINGS, INC. | Ctt Pharmaceutical Holdings, Inc. CEO | $403 16,100 shares | +0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.